Filter Results :

Your search for Lymphoma returned 126 reports

Sort by


Non-Hodgkin Lymphoma Partnering 2010-2015

01 Mar 2015  |  Published by:  CurrentPartnering
The Non-Hodgkin Lymphoma Partnering 2010-2015 report provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. -Trends in non-hodgkin lymphoma partnering deals-Top non-hodgkin lymphoma deals by value-De...

$ 795.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

24 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Peripheral T-Cell Lymphomas (PTCL), complete with comparativ...

$ 2,000.00

Read More

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

18 Feb 2015  |  Published by:  Global Markets Direct
Summary‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for B-Cell Non-Hodgkin Lymphoma, complete with comparative analysis at various...

$ 2,000.00

Read More

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015

10 Feb 2015  |  Published by:  Global Markets Direct
Summary‘Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Acute Lymphoblastic Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Lymphoblastic Lymphoma, complete with comparative analysis at vari...

$ 2,000.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Large Cell Lymphom...

$ 2,000.00

Read More

Indolent Lymphoma - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Indolent Lymphoma, complete with comparative analysis at various stag...

$ 2,000.00

Read More

Mantle Cell Lymphoma - Pipeline Review, H1 2015

30 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Mantle Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Mantle Cell Lymphoma, complete with comparative analysis at various stages, therapeutics...

$ 2,000.00

Read More

Hodgkin Lymphoma - Pipeline Review, H1 2015

22 Jan 2015  |  Published by:  Global Markets Direct
Summary‘Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Hodgkin Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Hodgkin Lymphoma, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014

31 Dec 2014  |  Published by:  Global Markets Direct
Summary ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Acute Lymphoblastic Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Acute Lymphoblastic Lymphoma, complete with comparative analysis at var...

$ 2,000.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014

15 Dec 2014  |  Published by:  Global Markets Direct
Summary‘Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2014’, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with c...

$ 2,000.00

Read More

Lymphoma Treatment Drugs Markets in China

01 Dec 2014  |  Published by:  Asia Market Info and Dev Co.
China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import &...

$ 4,000.00

Read More

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

21 Nov 2014  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, such as fund raising, patient services, health education, policy advocacy and medical research...

$ 250.00

Read More

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

21 Nov 2014  |  Published by:  GlobalData
SummaryThe Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare organization. The organization provides funding to blood cancer research, and offers education and patient services. It provides services, such as fund raising, patient services, health education, policy advocacy and medical research...

$ 300.00

Read More

Non Hodgkin Lymphoma Therapeutics Market & Pipeline Insight

10 Nov 2014  |  Published by:  KuicK Research
The market for Non Hodgkin Lymphoma has significant unmet medical necessities in terms of demand for innovative drugs and novel technologies. This is one of the major factors behind the market witnessing rapid growth in Non Hodgkin Lymphoma segment. Past few decades have witnessed an increased...

$ 2,400.00

Read More

Lymphoma Partnering 2010-2015

01 Nov 2014  |  Published by:  CurrentPartnering
The Lymphoma Partnering 2009-2014 provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of lymphoma partnering deals. The majority of deals are discovery or development stage...

$ 995.00

Read More
Total 126 records.